跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
找到 13,142 条关于
“JAK-STAT signaling pathway”
全部
13,142
临床试验
5,419
药物
691
机构
187
资讯
6,845
去年
JAK Inhibitors Show Promise as First-Ever Cure for Toxic Epidermal Necrolysis
去年
JAK Inhibitors Pipeline Expands with 55+ Drug Candidates as Major Pharma Companies Drive Innovation
去年
InnoCare Doses First Subject in Phase III Trial of TYK2 Inhibitor ICP-332 for Atopic Dermatitis
3个月前
JAK-STAT1-MED15 Axis Drives Melanocyte Dysfunction in Vitiligo, Study Reveals
去年
JAK Inhibitor Pipeline Shows Robust Growth with 55+ Therapies in Development Across Multiple Therapeutic Areas
去年
InnoCare Doses First Subject in Phase III Trial of TYK2 Inhibitor ICP-332 for Atopic Dermatitis
5年前
Advances in Prognostication and Treatment of Polycythemia Vera with Pegylated Interferon and MDM2 Inhibition
9个月前
InnoCare Initiates Global Phase II Trial of TYK2 Inhibitor Soficitinib for Prurigo Nodularis Treatment
2年前
Spatial Profiling Reveals Predictive Signatures for Pembrolizumab Response in Bladder Cancer
去年
Incyte's Povorcitinib Shows Significant Efficacy in Phase 3 Trials for Hidradenitis Suppurativa
第 1 页,共 685 页
上一页
下一页